Lumos Pharma Inc reports results for the quarter ended in September - Earnings Summary

Lumos Pharma

14/11/2022 22:02

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted
loss
of 86 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of $1.01 per share.
    * Revenue was $497.00 thousand​; analysts expected $66.67
thousand. 
    * Lumos Pharma Inc's reported EPS for the quarter was a loss
of 86
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lumos Pharma Inc shares had risen by 0.7% this quarter and
gained 28.6% so far this year.
    * The company reported a quarterly loss of $7.25 million.
    * Wall Street's median 12-month price target for Lumos
Pharma Inc
is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -1.01          -0.86          Beat
 Jun. 30 2022      -0.99          -0.94          Beat
 Mar. 31 2022      -0.89          -0.92          Missed
 Dec. 31 2021      -0.92          -0.67          Beat